Pds biotech announces achievement of an enrollment objective in national cancer institute-led phase 2 clinical trial of pds0101-based combination in advanced hpv-associated cancers

Nci achieves the enrollment objective of thirty patients in the checkpoint inhibitor refractory arm of the study nci achieves the enrollment objective of thirty patients in the checkpoint inhibitor refractory arm of the study
PDSB Ratings Summary
PDSB Quant Ranking